等待開盤 03-26 09:30:00 美东时间
-2.950
-1.55%
Danaher announces annual shareholder meeting; FY2025 sales rise to $24.6 billion Danaher will hold its annual meeting on May 5, 2026, conducted virtually via www.virtualshareholdermeeting.com/DHR2026. Shareholders are scheduled to vote on electing 11 directors to serve until the 2027 annual meeting.
03-25 20:11
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:18
WASHINGTON, March 20, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2026 on Tuesday, April ...
03-21 04:15
经济观察网 2026年3月17日,丹纳赫生命科学平台旗下品牌IDT(Integrated DNA Technologies)与国内新药研发平台普瑞基准签署战略合...
03-20 23:38
EXCLUSIVE-Altai Capital presses OraSure to sell and give it board seats, letter says Altai says OraSure is worth more sold than operating as a standalone company Altai pressing for board seats after nominating two directors in January Altai says board failed to prevent missteps, pushes for new direc
03-17 20:00
• 丹纳赫(Danaher Corp)受行业逆风影响,股价日内下跌。 • 耗资99亿美元收购Masimo导致公司债务增加,引发整合担忧。 • 保守的2026年业绩指引和技术指标均暗示投资者应保持谨慎。
03-12 18:16
• Danaher Corp saw intraday decline amid industry headwinds. • $9.9 billion Masimo acquisition increases debt, raising integration concerns. • Conservative 2026 guidance and technical indicators suggest caution.
03-12 18:15
WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its...
02-25 05:30
摘要:丹纳赫2026年2月18日宣布以约99亿美元收购Masimo,溢价超40%,预计2026年下半年完成。Masimo将作为其诊断业务部门内独立公司运营,增强...
02-24 16:59
经济观察网 丹纳赫(DHR.N)于2月17日宣布以约99亿美元全现金收购医疗设备公司Masimo(MASI.OQ)。根据协议,丹纳赫将以每股180美元的价格收购...
02-20 02:54